Nyra Medical
  • Home
  • CARLEN TLAR
  • TEAM
  • NEWS
  • CAREERS

Biomechanical effects of CARLEN vs. MitraClip to be presented at the World Congress of Biomechanics 2022 
CARLEN is a more physiologically apt repair than current TEER technologies. Come see us present our data on this topic and why it matters in the long run for patients
Picture

Efficacy data on CARLEN's ability to repair FMR in a variety of etiologies to be presented at the 2022 annual meeting of the Heart Valve Society
Come check us out at the Mitral Valve 2 session - modern concepts in functional mitral regurgitation on Friday, March 4, 2022
Picture

Picture

CARLEN technology was presented at the Scientific Sessions of the American Heart Association

Nov 2021: The CARLEN technology to be presented as a moderated presentation at the 2021 Scientific Sessions of the American Heart Association to be held in Nov 2021
Picture

CARLEN technology licensed from Emory University

Jan 2021: Nyra Medical acquires exclusive, world wide rights to the cardiac leaflet enhancer technology portfolio of patents from Emory University
Picture

Nyra Medical selected as a finalist at the TCT Shark Tank

Sept 2019: Nyra Medical was selected as a finalist for the TCT shark tank, that showcases the up and coming novel technologies in interventional cardiology.
Picture
Nyra Medical CARLEN is an investigational device only and not available for sale in any geography
  • Home
  • CARLEN TLAR
  • TEAM
  • NEWS
  • CAREERS